PASTORELLI, LUCA
 Distribuzione geografica
Continente #
EU - Europa 5.314
NA - Nord America 3.667
AS - Asia 1.890
SA - Sud America 82
OC - Oceania 33
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.007
Nazione #
US - Stati Uniti d'America 3.590
GB - Regno Unito 2.627
CN - Cina 928
IT - Italia 741
SE - Svezia 544
DE - Germania 418
SG - Singapore 237
IN - India 190
IE - Irlanda 174
FR - Francia 166
KR - Corea 98
TR - Turchia 97
JP - Giappone 95
GR - Grecia 93
UA - Ucraina 93
FI - Finlandia 83
HK - Hong Kong 82
DK - Danimarca 73
RU - Federazione Russa 72
CA - Canada 69
ID - Indonesia 66
ES - Italia 59
NL - Olanda 39
BR - Brasile 38
AU - Australia 25
PL - Polonia 24
BE - Belgio 22
NO - Norvegia 21
EU - Europa 19
VN - Vietnam 19
CH - Svizzera 17
CO - Colombia 17
CZ - Repubblica Ceca 12
IR - Iran 12
UZ - Uzbekistan 12
CL - Cile 11
TW - Taiwan 10
NZ - Nuova Zelanda 8
PT - Portogallo 8
RO - Romania 8
AT - Austria 7
MY - Malesia 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
MX - Messico 5
PH - Filippine 5
TH - Thailandia 5
IL - Israele 4
LK - Sri Lanka 4
AR - Argentina 3
BD - Bangladesh 3
EC - Ecuador 3
EG - Egitto 3
SC - Seychelles 3
VE - Venezuela 3
ZA - Sudafrica 3
AP - ???statistics.table.value.countryCode.AP??? 2
LB - Libano 2
PK - Pakistan 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BT - Bhutan 1
BZ - Belize 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
IQ - Iraq 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 11.024
Città #
Southend 2.483
Chandler 465
Fairfield 330
Seattle 286
Wilmington 241
Milan 238
Ashburn 210
Princeton 189
Dublin 174
Woodbridge 173
Beijing 166
Singapore 139
Houston 136
Cambridge 121
Ann Arbor 118
Dearborn 104
Hanover 85
Frankfurt am Main 79
Redwood City 76
Des Moines 71
Nanjing 71
Bengaluru 63
Hong Kong 55
Jakarta 54
Shanghai 52
Guangzhou 51
Redmond 46
Andover 45
Phoenix 44
Jacksonville 43
Boardman 41
Berlin 35
Mountain View 35
New York 34
Chengdu 31
Helsinki 31
Shenyang 31
Tokyo 28
London 27
Jinan 25
Turin 25
Toronto 24
Rome 22
Ottawa 20
Seoul 19
Chicago 18
San Diego 18
Wuhan 18
Hangzhou 17
Nanchang 17
Warsaw 17
Changsha 16
Saint Petersburg 16
Serra 16
Hefei 15
Madrid 15
Bitonto 14
Istanbul 14
Athens 13
Como 13
Costa Mesa 13
Ningbo 13
Bogotá 12
Brussels 12
Hebei 12
Nuremberg 12
San Francisco 12
Upper Marlboro 12
Zhengzhou 12
Central District 11
Fremont 11
Paris 11
Tianjin 11
Hyderabad 10
Lanzhou 10
Silver Spring 10
Bühl 9
Jiaxing 9
Munich 9
Sakarya 9
Somerville 9
Xian 9
Amsterdam 8
Barcelona 8
Brno 8
Central 8
Eitensheim 8
Erlangen 8
Los Angeles 8
Santiago 8
Auburn Hills 7
Catania 7
Duncan 7
Edinburgh 7
Grafing 7
Harbin 7
Kunming 7
Livingston 7
Modena 7
Nagoya 7
Totale 7.445
Nome #
Contribution of Extracellular Matrix and Signal Mechanotransduction to Epithelial Cell Damage in Inflammatory Bowel Disease Patients: A Proteomic Study 559
Terminal ileum ileoscopy and histology in patients undergoing high-definition colonoscopy with virtual chromoendoscopy for chronic nonbloody diarrhea : a prospective, multicenter study 394
Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion 260
Outcomes of COVID-19 in 79 patients with IBD in Italy : an IG-IBD study 250
Major duodenal papilla prolapse in Cronkhite-Canada syndrome 213
Small-bowel capsule endoscopy with panoramic view : results of the first multicenter, observational study (with videos) 204
Extensive small-bowel Crohn's disease detected by the newly introduced 360° panoramic viewing capsule endoscopy system 199
Hold the Foam : Why Topical Budesonide Remains Relevant for IBD Therapy 192
Editorial : the increasing burden of microscopic colitis 188
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MMxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report of a pilot study 180
Bowel Sonoelastography in Patients with Crohn's Disease : a Systematic Review 178
Over-the-scope clip-assisted endoscopic full-thickness resection after incomplete resection of rectal adenocarcinoma 176
The role of IL-33 in gut mucosal inflammation 169
Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function 169
Interleukin-33 selectively expands interleukin-17 producing CD 11b+ cell population in an experimental model of spontaneus intestinal inflammation 167
Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism 167
IL-33 activates tumor stroma to promote intestinal polyposis 165
Biomarkers and Microscopic Colitis : An Unmet Need in Clinical Practice 164
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MmxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report a pilot study 160
Outcome of transfusion-associated chronic hepatitis C depends on patient age at infection 159
Adrenal incidentalomas (AI) in patients with hereditary hemochromatosis (HH) 158
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 157
Aberrant expression of IFI16 in the intestinal epithelia from inflammatory bowel disease is induced by pro-inflammatory cytokines 153
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MMxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report of a pilot study 152
Prevalence of microscopic colitis in subjects undergoing colonoscopy for non-bloody diarrhea : a prospective epidemiological study 151
Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation : Lessons Learned from Animal Models and Human Genetics 150
Associations between genetic polymorphism in IL-33, IL1R1 and risk for inflammatory bowel disease 149
Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity? 144
Do antibodies have a role in IBD pathogenesis? 131
A consumer's guide for probiotics : 10 golden rules for a correct use 129
Inflammatory bowel disease (IBD) : biomarkers identification by proteomic approach 124
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis 122
Emerging drugs for the treatment of ulcerative colitis 119
Hepcidin is a pivotal mediator of infliximab-induced improvement of iron metabolism in inflammatory bowel diseases 119
Role, efficacy and safety of budesonide multi-matrix in ulcerative colitis in real life: A study in three Italian third-level centres 117
Microscopic colitis and colorectal neoplastic lesions in patients with chronic non-bloody diarrhea : a prospective multicenter study 116
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 115
Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea : a prospective, multicenter study 114
Prevalence and clinical significance of antibodies anti-IFI 16 in inflammatory bowel diseases 113
Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives 113
Endoscopic full-thickness resection for T1 early rectal cancer : a case series and video report 112
A rare case of angina bullosa hemorrhagica of the esophagus 112
Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis 111
In-vivo axial-strain sonoelastography helps distinguish acutely-inflamed from fibrotic terminal ileum strictures in patients with Crohn's disease : preliminary results 111
SAMP1/YitFc mouse strain : a spontaneous model of Crohn's disease-like ileitis 110
Infliximab-Mediated modulation of Hepcidin improves iron metabolism in Inflammatory Bowel Disease 109
Dichotomous effects of interleukin-33 on gastric and intestinal epithelial cell proliferation 106
MMX® technology and its applications in gastrointestinal diseases 106
Corrigendum: Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice (Frontiers in Medicine, (2017), 4, 10.3389/fmed.2017.00054) 105
IL-33 triggers early eosinophil-dependent events leading to metaplasia in a chronic model of gastritis-prone mice 103
PC.1.3: IL-33-dependent induction of intestinal profibrotic gene expression and myofibroblast hypertrophy : potential role in inflammatory-associated gut fibrosis 102
Proinflammatory Interleukin-33 Induces Dichotomic Effects on Cell Proliferation in Normal Gastric Epithelium and Gastric Cancer 102
Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a "Red Zone" Area in Northern Italy 99
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy 98
Severe azathioprine-induced liver injury 22 months after initiation of treatment 96
Spontaneous, immune-mediated gastric inflammation in SAMP1/YitFc mice, a model of Crohn's-like gastritis 95
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study 93
Advances in endoscopic imaging in ulcerative colitis 92
Ex vivo experimental study on the Thulium laser system : new horizons for interventional endoscopy (with videos) 92
IL-33-dependent induction of intestinal profibrotic gene expression and myofibroblast hypertrophy : potential role in inflammatory-associated gut fibrosis 90
Distinct Anti-IFI16 and Anti-GP2 antibodies in inflammatory bowel disease and their variation with infliximab therapy 90
Usefulness of panoramic 344°-viewing in Crohn's disease capsule endoscopy : a proof of concept pilot study with the novel PillCam™ Crohn's system 90
High prevalence of antibodies anti-interferon-inducible IFI16 protein in inflammatory bowel diseases 89
Idea for in vivo differentiation of ulcerative colitis and Crohn's disease with confocal laser endomicroscopy 89
Over-the-scope clipping in recurrent colonic diverticular bleeding 86
Proteomic insights on the metabolism in inflammatory bowel disease 86
Pro-inflammatory cytokines Induce aberrant interferon-inducible IFI16 protein expression in inflammatory bowel disease epithelium 85
Microscopic colitis and colorectal neoplastic lesions in patients with chronic non-bloody diarrhea : a prospective, Multicenter Study 84
Novel cytokine signaling pathways in inflammatory bowel disease : insight into the dichotomous functions of IL-33 during chronic intestinal inflammation 81
Thulium laser in interventional endoscopy : animal and human studies 81
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis : a real-life experience 80
Efficacy and tolerability of high and low-volume bowel preparation compared : A real-life single-blinded large-population study 74
Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy : an IG-IBD study 72
Use of an over-the-scope clip for endoscopic sealing of anastomotic dehiscence after anterior resection for rectal cancer 72
In vitro effect of Interleukin-33 on gastric adenocarcinoma cell line (AGS) and intestinal epithelial cancer cell line (Caco-2) 67
IL-33 drives eosinophil infiltration and pathogenic type 2 helper T-cell immune responses leading to chronic experimental ileitis 67
Mo1779 interleukin-33 induces distinct gastric epithelial alterations and plays an important role in the pathogenesis of murine gastritis 67
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis 67
Anti-TNF Therapy Improves Stored Body Iron Serum Markers in Inflammatory Bowel Disease Patients 66
Multidimensional Prognostic Index Predicts Clinical Outcome and Mortality in Hospitalised Older Patients with Diverticular Disease 60
Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD : A Domino Effect 53
Microscopic Colitis : What Do We Know About Pathogenesis? 53
Interleukin-37 : a Peacekeeper at the Intestinal Borders 52
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 52
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system 49
Staging esophageal cancer: low EUS accuracy in t2n0 patients 47
Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis 46
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 46
Response to "italian ibd patients coping with covid-19 emergency : The mitigating role of psychological readiness to engage in self-care 45
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease 43
AN update on probiotic therapy for chronic inflammatory bowel diseases in adults 43
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 43
Low prevalence of colorectal neoplasia in microscopic colitis : A large prospective multi-center study 42
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 39
Editorial: The Dark Side of Microscopic Colitis 38
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis 35
Constrained multiple instance learning for ulcerative colitis prediction using histological images 34
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 33
Surveillance strategies for colitis-associated cancer : state of the art and future perspectives 33
I farmaci biologici nelle malattie infiammatorie croniche intestinali 33
Totale 11.415
Categoria #
all - tutte 36.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.606 121 54 54 167 103 264 134 116 238 168 116 71
2020/20212.116 189 159 143 134 192 139 108 190 233 169 285 175
2021/20222.032 181 165 147 194 166 141 143 133 245 187 63 267
2022/20231.778 189 171 157 186 174 303 50 96 187 67 149 49
2023/20241.403 68 99 89 72 333 93 90 97 37 85 154 186
2024/2025112 112 0 0 0 0 0 0 0 0 0 0 0
Totale 11.699